Diseases, Conditions, Syndromes

T-cells with a license to kill viruses

A research group led by Kyoto University has produced the world's first pluripotent stem cell-derived killer T-cell drug to treat COVID-19. The University has filed a patent application ahead of full-scale drug development.

Genetics

Array pinpoints imprinted genes with potential links to disease

Researchers from North Carolina State University have developed an array that assesses methylation levels of genes located in imprint control regions (ICRs) within the human genome. The array represents a cost-effective, ...

Parkinson's & Movement disorders

Could AI be the answer to early Parkinson's disease diagnoses?

Parkinson's disease is a significant health concern with profound impacts on individuals, the health care system and broader society. The current diagnosis model, which heavily relies on a medical professional interpreting ...